131 related articles for article (PubMed ID: 2950175)
1. Determination of co-expression of activation antigens on proliferating CD4+, CD4+ CD8+ and CD8+ lymphocyte subsets by dual parameter flow cytometry.
Creemers PC
J Immunol Methods; 1987 Mar; 97(2):165-71. PubMed ID: 2950175
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
4. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subsets and activation antigens in a reference population: a flow cytometric study using single and double antibody staining.
Schuerch C; Fleetwood M; Glidewell O
Immunol Invest; 1987 Jun; 16(4):345-60. PubMed ID: 2828230
[TBL] [Abstract][Full Text] [Related]
6. Restoration of impaired B- and T-lymphocyte subsets and functions in vitro by isoprinosine in prodromal homosexuals and AIDS patients.
Tsang PH; Zanjani MD; Warner N; Bekesi JG
J Clin Lab Immunol; 1986 Aug; 20(4):159-65. PubMed ID: 2428980
[TBL] [Abstract][Full Text] [Related]
7. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
8. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.
Yacyshyn MB; Poppema S; Berg A; MacLean GD; Reddish MA; Meikle A; Longenecker BM
Int J Cancer; 1995 May; 61(4):470-4. PubMed ID: 7538976
[TBL] [Abstract][Full Text] [Related]
9. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
10. [Activation of T lymphocytes and severity of atopic bronchial asthma in children].
Bartkowiak M; Kołecki P; Alkiewicz J
Pneumonol Alergol Pol; 1995; 63(9-10):490-7. PubMed ID: 8620168
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the staining of peripheral blood T lymphocytes by various anti-CD8 and HLA-DR monoclonal antibodies.
Kootte AM; Langelaar RA; Tanke HJ; Van der Voort EA; Paul LC
J Immunol Methods; 1988 Jun; 111(1):75-82. PubMed ID: 2455754
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.
Ginaldi L; Farahat N; Matutes E; De Martinis M; Morilla R; Catovsky D
J Clin Pathol; 1996 Jul; 49(7):539-44. PubMed ID: 8813949
[TBL] [Abstract][Full Text] [Related]
13. Single laser flow cytometric detection of lymphocytes binding three antibodies labelled with fluorescein, phycoerythrin and a novel tandem fluorochrome conjugate.
Festin R; Björkland A; Tötterman TH
J Immunol Methods; 1990 Jan; 126(1):69-78. PubMed ID: 2137494
[TBL] [Abstract][Full Text] [Related]
14. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM.
Hehmke B; Michaelis D; Gens E; Laube F; Kohnert KD
Diabetes; 1995 Dec; 44(12):1414-9. PubMed ID: 7589848
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
[TBL] [Abstract][Full Text] [Related]
16. Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors.
Lenkei R; Andersson B
J Immunol Methods; 1995 Jun; 183(2):267-77. PubMed ID: 7602149
[TBL] [Abstract][Full Text] [Related]
17. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
Li T; Qiu Z; Wang A; Sheng R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
[TBL] [Abstract][Full Text] [Related]
18. Analysis of peripheral blood lymphocyte cell surface density of functional and activation associated markers in young and old hemodialysis patients.
Shabtai M; Avigad I; Schachter P; Czerniak A; Judich A; Ayalon A
J Urol; 1993 Nov; 150(5 Pt 1):1369-74. PubMed ID: 8411402
[TBL] [Abstract][Full Text] [Related]
19. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
20. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
